180 Life Sciences Corp.
General ticker "ATNF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $6.7M (TTM average)
180 Life Sciences Corp. follows the US Stock Market performance with the rate: 25.2%.
Estimated limits based on current volatility of 9.1%: low 2.35$, high 2.82$
Factors to consider:
- Top business risk factors: Strategic risks and growth management, Operational and conduct risks, Supply chain disruptions, Litigation risks, Regulatory and compliance
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.12$, 6.29$]
- 2024-12-30 to 2025-12-30 estimated range: [0.76$, 3.86$]
Financial Metrics affecting the ATNF estimates:
- Negative: with PPE of -0.1 at the end of fiscal year the price was very high
- Negative: Shareholder equity ratio, % of -2.43 <= 19.78
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -804.73 <= 0.99
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -24.55 <= 2.30
- Positive: Interest expense per share per price, % of 0 <= 0.71
Short-term ATNF quotes
Long-term ATNF plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $15.64MM | $17.90MM | $13.48MM |
| Operating Income | $-15.64MM | $-17.90MM | $-13.48MM |
| Non-Operating Income | $-4.71MM | $-21.77MM | $-8.81MM |
| Interest Expense | $0.19MM | $0.03MM | $0.00MM |
| R&D Expense | $3.95MM | $2.43MM | $2.78MM |
| Income(Loss) | $-20.35MM | $-39.67MM | $-22.28MM |
| Taxes | $-0.02MM | $-0.94MM | $-2.35MM |
| Profit(Loss)* | $-20.28MM | $-38.73MM | $-19.94MM |
| Stockholders Equity | $39.32MM | $11.34MM | $-0.13MM |
| Assets | $62.71MM | $19.65MM | $5.26MM |
| Operating Cash Flow | $-19.37MM | $-12.13MM | $-10.92MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $0.08MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $25.41MM | $10.87MM | $5.91MM |
| Earnings Per Share** | $-247.30 | $-387.26 | $-52.60 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.